{"nct_id":"NCT02512042","title":"Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes","status":"COMPLETED","status_verified_date":"2020-02","start_date":"2015-04","start_date_type":"ACTUAL","primary_completion_date":"2016-04","primary_completion_date_type":"ACTUAL","completion_date":"2016-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TEVA"]}